Tags Drug development Eli Lilly to Spend $3.5 Billion on New U.S. Plant for Next-Gen Obesity Drugs businessx January 31, 2026 Eli Lilly is doubling down on its push to dominate the fast-growing obesity drug market. The pharmaceutical giant announced plans
